Apigenin inhibits growth and migration of fibroblasts by suppressing FAK signaling

Aging (Albany NY). 2019 Jun 5;11(11):3668-3678. doi: 10.18632/aging.102006.

Abstract

The naturally occurring compound apigenin has many biological effects, including anti-inflammatory, antioxidative and anticancer effects. Although hypertrophic scar formation is a common surgical complication, there is still no good treatment for it. In the present study, we examined the effect of apigenin on hypertrophic scar. After isolating fibroblasts from human hypertrophic scars, we assess the effects of apigenin on fibroblast cell survival, apoptosis and migration. The results showed that apigenin dose-dependently inhibited the growth and migration of hypertrophic scar fibroblasts. By inhibiting FAK kinase activity and FAK phosphorylation, apigenin also inhibited activation of the FAK signaling pathway. Apigenin thus appears to inhibit the growth and migration of hypertrophic scar fibroblasts by inhibiting FAK signaling. This suggests apigenin could potentially provide a new option for the treatment of hypertrophic scars.

Keywords: FAK; apigenin; hypertrophic scar; phosphorylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apigenin / pharmacology*
  • Apoptosis / drug effects
  • Cell Movement / drug effects*
  • Cell Proliferation / drug effects*
  • Cell Survival / drug effects
  • Cicatrix, Hypertrophic / metabolism*
  • Female
  • Fibroblasts / drug effects*
  • Fibroblasts / metabolism
  • Focal Adhesion Kinase 1 / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Phosphorylation / drug effects
  • Signal Transduction / drug effects*

Substances

  • Apigenin
  • Focal Adhesion Kinase 1
  • PTK2 protein, human